Maybe everyone figured out there is only one director and they only merged with a holding company? I'm an investor, but strictly due to the chart and short term hype.
I honestly don't see how this company is now worth 6x more (in share price) than they were a month ago. The company they merged with doesn't appear to have any assets.
Is this all hype on them working towards SEC compliance for OTC pink? I suppose that does offer a huge potential.
With public float of about $800m times the current share price of .0006 that translates to only $480k worth of liquid capital. The upwards potential is certainly modestly higher than the downside, but I still don't see what near term catalysts we may see in order to keep eyes on this OTC. If risk of R/S being squashed didn't pump the price I'm not sure what will...
News 
Market Data 
Discover 
